Opko Health Inc.

OPKNASDAQ • USD
ThemeGenomics & Precision Med.›Genetic Testing & Diagnostics
1.46 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
1.47
↗ 0.01 (0.41%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
1.47
↗ 0.01 (0.41%)
🔴Market: CLOSED
Open?$1.47
High?$1.48
Low?$1.41
Prev. Close?$1.46
Volume?2.6M
Avg. Volume?2.7M
VWAP?$1.45
Rel. Volume?0.97x
Bid / Ask
Bid?$1.22 × 100
Ask?$1.66 × 100
Spread?$0.44
Midpoint?$1.44
Valuation & Ratios
Market Cap?1.1B
Shares Out?755.1M
Float?330.1M
Float %?43.5%
P/E Ratio?N/A
P/B Ratio?0.92
EPS?-$0.28
Dividend?0.00%
Ex-Dividend?N/A

Opko Health Inc. (OPK) trades at $1.48 per share. OPK shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 4, 2026.

News
Profile
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Themes
Healthcare - Genomics & Precision Medicine›Genetic Testing & DiagnosticsBiotech - Drug Development›Clinical-Stage Platforms
Employees
2.3K
Market Cap
1.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.opko.com
Listed
1995-11-02
Address
4400 BISCAYNE BLVD.
MIAMI, FL 33137
Phone: 305-575-4181
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
1
Momentum?
17
Short Sent.?
48
Piotroski F-Score?3/9Weak
Altman Z-Score?-0.55Distress
Confidence?64%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?9.89%Elevated
Short Interest?32.7M
Days to Cover?16.5
Free Float330.1M
Avg Daily Volume2.0M
Settlement Date2026-05-15
Financial Health
Current Ratio?3.61Strong
Quick Ratio?3.17Strong
Cash Ratio?2.30Strong
Debt/Equity?0.29Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.92CHEAP▾
P/S?
Peers
100
S&P
69
1.90CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-9.8CHEAP▾
EV/Sales?
Peers
100
S&P
77
1.90CHEAP▾
Returns & Efficiency
ROE?
S&P
8
-17.7%WEAK▾
ROA?
S&P
3
-11.5%WEAK▾
Cash Flow & Enterprise
FCF?$-174215000
Enterprise Value?$1.1B
Fundamentals ratios updated end of day
MarketsMoversWatchlist